Your session is about to expire
← Back to Search
Internet-Delivered Pain Management for Chemotherapy-Induced Nerve Pain
Study Summary
This trial is testing an internet-based pain coping program for cancer survivors with nerve pain. They will assess how well the program works and how it affects pain, function, psychological distress, and coping.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have finished all my cancer treatments except for ongoing maintenance therapy.I am able to care for myself and perform daily activities.I have cancer that needs treatment which may affect my nerves.I do not have a working email address.I experience moderate to severe numbness, pain, or weakness in my hands or feet after chemotherapy.My cancer is growing or getting worse.I cannot complete study activities due to a disability or condition.I had nerve pain or tingling before starting chemotherapy.I am currently taking buprenorphine or suboxone.I am currently enrolled in hospice or end-of-life care.I experience pain or discomfort on most days of the week.It has been over 2 years since I started chemotherapy that can affect the nerves.I am 18 years old or older.My medication has not changed in the last 30 days.
- Group 1: Internet delivered pain coping
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available vacancies for individuals to participate in this experiment?
"This clinical trial is not recruiting at present, as indicated on the website of clinicaltrials.gov. Last updated in October 25th 2022, this study was first posted January 1st 2023. Although there are no applicants being accepted for this particular medical trial today, 161 other trials are actively seeking candidates to participate in them."
What results is the team hoping to achieve through this medical experiment?
"The primary goal of this 12-week trial is to measure the Adherence Rate. Secondary objectives include evaluating change in Psychological distress Scores (General Anxiety Disorder scale - GAD 7) ranging from 0-4 (minimal anxiety), 5-9 (mild anxiety), 10-14(moderate anxiety) and 15-21 (severe anxiety); Change in Objective physical function Scores via PROMIS Functional Assessment of Chronic Illness Therapy Fatigue Scale, which uses a 4 point Likert scale ranging from 'not at all fatigued' to 'very much fatigued'; and lastly Change in Objective physical function Scores through Patient Reported Out"
Share this study with friends
Copy Link
Messenger